{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:15:31Z","timestamp":1789017331698,"version":"build-2803163510"},"reference-count":26,"publisher":"American Society of Hematology","issue":"6","license":[{"start":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T00:00:00Z","timestamp":1705449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,3,26]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>Liver disease has not been well described in patients with Fanconi anemia (FA). Improvements in outcomes of transplant mean that more individuals with FA are reaching adulthood and new features of the FA phenotype are being discovered. We performed a retrospective review of liver function in a cohort of 97 patients with FA followed-up for at least 10 years at a single center. We identified a high frequency of transaminitis (n\u00a0= 31, 32%) without elevation of bilirubin and with no evidence of structural hepatic abnormality in patients with FA. Transaminitis was persistent in many cases, sometimes lasting more than a decade without clinical manifestation, although 2 patients with prolonged transaminitis are deceased from liver failure, indicating important long-term clinical consequences. Transaminitis was found in patients who had and had not received transplant but was more frequent in recipients of transplant. Exposure to total body irradiation increased risk (odds ratio, 15.5 [95% confidence interval, 2.44-304.54]; P\u00a0= .01), whereas treatment with androgens did not. Review of limited numbers of liver biopsies and autopsy material showed a cholestatic pattern of liver injury, with progressive fibrosis, in the majority of patients. Occurrence in cases without transplant as well as cases with transplant argues against a potential diagnosis of atypical liver graft-versus-host disease. Limited data regarding therapy suggest no benefit from treatment with steroids or other immune suppressive medications or ursodeoxycholic acid. Our data show that liver disease is common in patients with FA, and because most children with FA now reach adulthood, end-stage liver disease in young adulthood means systematic testing of potential therapies is urgently needed.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2023012215","type":"journal-article","created":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T15:41:29Z","timestamp":1705506089000},"page":"1427-1438","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":5,"title":["Liver abnormalities are frequent and persistent in patients with Fanconi anemia"],"prefix":"10.1182","volume":"8","author":[{"given":"Alana J.","family":"Snyder","sequence":"first","affiliation":[{"name":"1Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9672-588X","authenticated-orcid":false,"given":"Kathleen M.","family":"Campbell","sequence":"additional","affiliation":[{"name":"2Department of Pediatrics, University of Cincinnati, Cincinnati, OH"},{"name":"3Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Lane","sequence":"additional","affiliation":[{"name":"1Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH"},{"name":"2Department of Pediatrics, University of Cincinnati, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parinda A.","family":"Mehta","sequence":"additional","affiliation":[{"name":"1Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH"},{"name":"2Department of Pediatrics, University of Cincinnati, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5528-4405","authenticated-orcid":false,"given":"Kasiani","family":"Myers","sequence":"additional","affiliation":[{"name":"1Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH"},{"name":"2Department of Pediatrics, University of Cincinnati, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella M.","family":"Davies","sequence":"additional","affiliation":[{"name":"1Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH"},{"name":"2Department of Pediatrics, University of Cincinnati, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1858-2881","authenticated-orcid":false,"given":"Jane","family":"Koo","sequence":"additional","affiliation":[{"name":"1Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH"},{"name":"2Department of Pediatrics, University of Cincinnati, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2024,3,15]]},"reference":[{"issue":"12","key":"2024032514303683600_bib1","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/carcin\/bgq210","article-title":"RAD51C: a novel cancer susceptibility gene is linked to Fanconi anemia and breast cancer","volume":"31","author":"Somyajit","year":"2010","journal-title":"Carcinogenesis"},{"issue":"4","key":"2024032514303683600_bib2","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1365-2141.2006.06049.x","article-title":"The association between FANCD1\/BRCA2 mutations and leukaemia","volume":"133","author":"Alter","year":"2006","journal-title":"Br J Haematol"},{"issue":"2","key":"2024032514303683600_bib3","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2141.2010.08212.x","article-title":"Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study","volume":"150","author":"Alter","year":"2010","journal-title":"Br J Haematol"},{"issue":"19","key":"2024032514303683600_bib4","doi-asserted-by":"crossref","first-page":"9591","DOI":"10.1158\/0008-5472.CAN-07-1501","article-title":"Genetic heterogeneity among Fanconi anemia heterozygotes and risk of cancer","volume":"67","author":"Berwick","year":"2007","journal-title":"Cancer Res"},{"issue":"14","key":"2024032514303683600_bib5","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1182\/blood-2010-08-299917","article-title":"Origin, functional role, and clinical impact of Fanconi anemia FANCA mutations","volume":"117","author":"Castella","year":"2011","journal-title":"Blood"},{"issue":"3","key":"2024032514303683600_bib6","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.molcel.2015.07.009","article-title":"A\u00a0dominant mutation in human RAD51 reveals its function in DNA interstrand crosslink repair independent of homologous recombination","volume":"59","author":"Wang","year":"2015","journal-title":"Mol Cell"},{"key":"2024032514303683600_bib7","doi-asserted-by":"crossref","first-page":"8829","DOI":"10.1038\/ncomms9829","article-title":"A\u00a0novel Fanconi anaemia subtype associated with a dominant-negative mutation in RAD51","volume":"6","author":"Ameziane","year":"2015","journal-title":"Nat Commun"},{"key":"2024032514303683600_bib8","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.gde.2015.07.002","article-title":"Fanconi anemia: a model disease for studies on human genetics and advanced therapeutics","volume":"33","author":"Bogliolo","year":"2015","journal-title":"Curr Opin Genet Dev"},{"issue":"1","key":"2024032514303683600_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jmg.2006.043257","article-title":"Clinical and molecular features associated with biallelic mutations in FANCD1\/BRCA2","volume":"44","author":"Alter","year":"2007","journal-title":"J\u00a0Med Genet"},{"issue":"6","key":"2024032514303683600_bib10","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.3390\/cancers15061871","article-title":"Early diagnosis of oral cancer and lesions in Fanconi anemia patients: a prospective and longitudinal study using saliva and plasma","volume":"15","author":"Errazquin","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"11","key":"2024032514303683600_bib11","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1093\/hmg\/ddad017","article-title":"A\u00a0novel cancer risk prediction score for the natural course of FA patients with biallelic BRCA2\/FANCD1 mutations","volume":"32","author":"Radulovic","year":"2023","journal-title":"Hum Mol Genet"},{"issue":"20","key":"2024032514303683600_bib12","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMra0809889","article-title":"Susceptibility pathways in Fanconi's anemia and breast cancer","volume":"362","author":"D'Andrea","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"2024032514303683600_bib13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/08880018.2015.1129567","article-title":"Androgen therapy in Fanconi anemia: a retrospective analysis of 30 years in Germany","volume":"33","author":"Paustian","year":"2016","journal-title":"Pediatr Hematol Oncol"},{"issue":"2","key":"2024032514303683600_bib14","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bcmd.2011.11.006","article-title":"Treatment of the bone marrow failure in Fanconi anemia patients with danazol","volume":"48","author":"Scheckenbach","year":"2012","journal-title":"Blood Cells Mol Dis"},{"issue":"1","key":"2024032514303683600_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/pbc.24617","article-title":"Oxandrolone for the treatment of bone marrow failure in Fanconi anemia","volume":"61","author":"Rose","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"2024032514303683600_bib16","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/pbc.25303","article-title":"Fanconi anemia and solid malignancies in childhood: a national retrospective study","volume":"62","author":"Malric","year":"2015","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"2024032514303683600_bib17","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1182\/blood-2002-07-2170","article-title":"A\u00a020-year perspective on the International Fanconi Anemia Registry (IFAR)","volume":"101","author":"Kutler","year":"2003","journal-title":"Blood"},{"issue":"5","key":"2024032514303683600_bib18","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/ajh.23153","article-title":"Incidence of liver abnormalities in Fanconi anemia patients","volume":"87","author":"Masserot-Lureau","year":"2012","journal-title":"Am J Hematol"},{"issue":"16","key":"2024032514303683600_bib19","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1182\/blood-2016-09-743112","article-title":"Radiation-free, alternative-donor HCT for Fanconi anemia patients: results from a prospective multi-institutional study","volume":"129","author":"Mehta","year":"2017","journal-title":"Blood"},{"issue":"12","key":"2024032514303683600_bib20","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.bbmt.2019.07.014","article-title":"Busulfan pharmacokinetics and precision dosing: are patients with Fanconi anemia different?","volume":"25","author":"Mehta","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"2024032514303683600_bib21","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/ajh.20183","article-title":"Androgens and liver tumors: Fanconi's anemia and non-Fanconi's conditions","volume":"77","author":"Velazquez","year":"2004","journal-title":"Am J Hematol"},{"issue":"11","key":"2024032514303683600_bib22","doi-asserted-by":"crossref","first-page":"e526","DOI":"10.1016\/S2352-3026(16)30114-4","article-title":"Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis","volume":"3","author":"Bartelink","year":"2016","journal-title":"Lancet Haematol"},{"issue":"4","key":"2024032514303683600_bib23","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jtct.2022.01.013","article-title":"Association between the magnitude of intravenous Busulfan exposure and development of hepatic veno-occlusive disease in children and young adults undergoing myeloablative allogeneic hematopoietic cell transplantation","volume":"28","author":"Bognar","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"8","key":"2024032514303683600_bib24","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s00277-015-2370-7","article-title":"Outcomes of mismatched and unrelated donor hematopoietic stem cell transplantation in Fanconi anemia conditioned with chemotherapy only","volume":"94","author":"Chao","year":"2015","journal-title":"Ann Hematol"},{"issue":"5","key":"2024032514303683600_bib25","doi-asserted-by":"crossref","first-page":"e14503","DOI":"10.1111\/petr.14503","article-title":"Successful sequential liver and hematopoietic stem cell transplantation in a patient with Fanconi anemia","volume":"27","author":"Di Stasio","year":"2023","journal-title":"Pediatr Transplant"},{"issue":"43","key":"2024032514303683600_bib26","doi-asserted-by":"crossref","first-page":"15623","DOI":"10.1074\/jbc.RA118.005729","article-title":"Sex-specific hepatic lipid and bile acid metabolism alterations in Fancd2\u2212 deficient mice following dietary challenge","volume":"294","author":"Moore","year":"2019","journal-title":"J\u00a0Biol Chem"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/6\/1427\/2218983\/blooda_adv-2023-012215-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/6\/1427\/2218983\/blooda_adv-2023-012215-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T14:31:04Z","timestamp":1711377064000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/6\/1427\/514603\/Liver-abnormalities-are-frequent-and-persistent-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,15]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,3,26]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023012215","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,15]]}}}